What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Antigen
His main research concerns Immunology, Antigen, Cytotoxic T cell, T lymphocyte and CD8.
His work deals with themes such as Molecular biology and In vitro, which intersect with Immunology.
His Antigen research incorporates elements of Antibody, Melanoma, Immune system and Transplantation.
His study looks at the relationship between Cytotoxic T cell and fields such as Cytotoxicity, as well as how they intersect with chemical problems.
His studies in CD8 integrate themes in fields like Epitope, T cell, Ex vivo and Effector.
His biological study spans a wide range of topics, including Cell biology, Tumor antigen, Immunotherapy and Cytolysis.
His most cited work include:
- Tumor-antigens recognized by T-lymphocytes (1206 citations)
- Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. (998 citations)
- Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 (551 citations)
What are the main themes of his work throughout his whole career to date?
Immunology, Antigen, Molecular biology, Cytotoxic T cell and CTL* are his primary areas of study.
His Immunology and T lymphocyte, Immune system, T cell, Spleen and Tumor antigen investigations all form part of his Immunology research activities.
His Antigen research includes themes of Antibody, Melanoma and Immunotherapy.
The concepts of his Molecular biology study are interwoven with issues in Cell culture, Lymphokine, MHC class I, Interleukin 2 and Monoclonal antibody.
His Cytotoxic T cell study incorporates themes from CD8 and T-cell receptor.
His work carried out in the field of CTL* brings together such families of science as Peptide, Cellular immunity, Cytolysis and Virology.
He most often published in these fields:
- Immunology (49.55%)
- Antigen (46.87%)
- Molecular biology (41.52%)
What were the highlights of his more recent work (between 2003-2013)?
- Immunology (49.55%)
- Cytotoxic T cell (37.05%)
- CD8 (24.11%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Immunology, Cytotoxic T cell, CD8, Antigen and T cell.
His studies deal with areas such as Ex vivo and Melanoma as well as Immunology.
His Cytotoxic T cell research focuses on subjects like T-cell receptor, which are linked to Avidity and NY-ESO-1.
His study on CD8 is covered under Immune system.
His Antigen research is multidisciplinary, incorporating elements of Cancer and Peptide library.
He has researched T cell in several fields, including Molecular biology, Dendritic cell and Effector.
Between 2003 and 2013, his most popular works were:
- Rapid and strong human CD8 + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909 (551 citations)
- Effector Function of Human Tumor-Specific CD8 T Cells in Melanoma Lesions: A State of Local Functional Tolerance (327 citations)
- Human Effector CD8+ T Lymphocytes Express TLR3 as a Functional Coreceptor (92 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Antibody
His scientific interests lie mostly in CD8, Immunology, Cytotoxic T cell, Antigen and Immune system.
As part of the same scientific family, he usually focuses on CD8, concentrating on T cell and intersecting with Dendritic cell.
Jean-Charles Cerottini combines topics linked to Melanoma with his work on Immunology.
He has included themes like Molecular biology and T lymphocyte in his Cytotoxic T cell study.
His research ties Biophysics and Antigen together.
His study in Immune system is interdisciplinary in nature, drawing from both Cancer, Tumor progression and Peptide vaccine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
